Catalyst Pharmaceuticals Inc (CPRX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 2.49B
P/E Ratio
12.35
Revenue (TTM)
$ 558.5M
Volume
0
52W High
$ 26.58
52W Low
$ 19.00
Dividend Yield
0.00%
Beta
0.70
Technicals
50-Day MA
21.0814
200-Day MA
22.381
52 Week High
26.58
52 Week Low
19
About CPRX
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
Employees
181
Headquarters
Coral Gables, FL
CEO
Mr. Richard John Daly M.B.A.
Latest News
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance
3 weeks ago • Google News